ASGCT | American Society Of Gene and Cell Therapy 2026, Boston
Last modified: 27/04/2026 - Author: Robin Oliveres
ASGCT 2026 Annual Meeting conference introduction
We are pleased to participate in the ASGCT 2026 Annual Meeting, the premier event in cell and gene therapy, taking place May 11–15, 2026 in Boston, USA at the Thomas M. Menino Convention & Exhibition Center. The meeting is organized by the American Society of Gene & Cell Therapy (ASGCT).
The scientific program features keynote lectures, plenary symposia, education sessions, workshops, and abstract-driven oral and poster presentations from leading academic, clinical, and industry voices. Topics covered span cell and gene therapy clinical translation, in vivo gene editing, RNA-LNP delivery, CGT manufacturing and automation, homology-directed repair, and emerging modalities across rare diseases, oncology, hematology, and neurology.
Date of the event: May. 12 to 14, 2026Where: Boston, USA
Let’s meet on May 11–15 in Boston to discuss the latest advances in cell and gene therapy!
Audrey Nsamela (our CSO), Thomas Gueriner (our CEO), and Robin Oliveres (our CBO and co-founder) will be there with TAMARA at our booth to discuss your RNA-LNP formulation projects, from screening to in vivo work.
We will also present a poster on NanoPulse, our patented technology for scalable LNP formulation across all scales. Poster session and number to be confirmed — stay tuned for updates.
You’ll find us at booth #1730. And stay tuned for the conference recap shortly after!
